UNSPSC 42295902: Tracheal stents

In this classification, this commodity indicates a product used as a stent conformed for tracheal procedures in a medical setting. US FDA regulates Tracheal stents under 21 CFR 878.3720 and under FDA product code JCT. Most nations, for tariff and trade purposes, schedule these products under HS 901839.

UNSPSC 42295902 Tracheal stents is a Commodity code representing single medical devices for airway management. The recent state and local procurement activity under this code shows minimal direct solicitation; the opportunities posted involve broader medical product and health-care service frameworks rather than tracheal stents specifically. State and local buyers accessing tracheal stents do so primarily through cooperative purchasing vehicles and master-agreement programs rather than standalone device RFPs. The Illinois Chief Procurement Office and Sourcewell cooperative, in partnership, solicited vendors for Physical Health Products and Related Services (RFP 102026, due October 20, 2026), a blanket master-agreement vehicle open to state departments, counties, cities, school districts, and higher-education institutions across multiple states. Such cooperative purchasing agreements establish pricing and terms for broad medical-device and supply categories available to member jurisdictions on call; tracheal stents would fall within the scope of eligible products under these frameworks but are not itemized as a standalone procurement line.

Geographic activity is concentrated in the upper Midwest and Pacific Northwest, anchored by Minnesota (Sourcewell's home state and cooperative-procurement hub) and Washington State (Washington State Department of Transportation medical-surveillance procurement). The other recent opportunities in the block—San Mateo Medical Center's orthopedic hardware extraction system services and Sourcewell's law-enforcement-equipment RFP—fall outside the scope of tracheal stents and do not represent relevant market signals. The code shows low standalone procurement velocity; business-development professionals should monitor cooperative purchasing vehicles and state health-department master-agreement amendments for indirect access points and pricing tiers rather than expect direct RFPs for tracheal stents alone.